126 related articles for article (PubMed ID: 32693902)
21. Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice.
Hoogervorst EM; de Vries A; Beems RB; van Oostrom CT; Wester PW; Vos JG; Bruins W; Roodbergen M; Cassee FR; Vijg J; van Schooten FJ; van Steeg H
Carcinogenesis; 2003 Mar; 24(3):613-9. PubMed ID: 12663525
[TBL] [Abstract][Full Text] [Related]
22. Trans- and cis-DNA adduct concentration in epidermis from mouse and rat skin treated ex vivo with benzo[a]pyrene diol epoxide and its corresponding chlorohydrin.
Vock EH; Wolfe AR; Meehan T
Mutat Res; 2001 Jul; 478(1-2):199-206. PubMed ID: 11406185
[TBL] [Abstract][Full Text] [Related]
23. In vivo formation of benzo(alpha)pyrene diol epoxide-deoxyadenosine adducts in the skin of mice susceptible to benzo(alpha)pyrene-induced carcinogenesis.
Ashurst SW; Cohen GM
Int J Cancer; 1981 Mar; 27(3):357-64. PubMed ID: 6270017
[TBL] [Abstract][Full Text] [Related]
24. DNA damage induced in mouse tissues by organic wood preserving waste extracts as assayed by 32P-postlabeling.
Randerath E; Zhou GD; Donnelly KC; Safe SH; Randerath K
Arch Toxicol; 1996; 70(11):683-95. PubMed ID: 8896714
[TBL] [Abstract][Full Text] [Related]
25. Species- and length of exposure-dependent differences in the benzo(a)pyrene:DNA adducts formed in embryo cell cultures from mice, rats, and hamsters.
Sebti SM; Pruess-Schwartz D; Baird WM
Cancer Res; 1985 Apr; 45(4):1594-600. PubMed ID: 3978626
[TBL] [Abstract][Full Text] [Related]
26. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
27. Correlation between DNA or protein adducts and benzo[a]pyrene diol epoxide I-triglyceride adduct detected in vitro and in vivo.
Kwack SJ; Lee BM
Carcinogenesis; 2000 Apr; 21(4):629-32. PubMed ID: 10753196
[TBL] [Abstract][Full Text] [Related]
28. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
[TBL] [Abstract][Full Text] [Related]
29. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
[TBL] [Abstract][Full Text] [Related]
30. Formation and persistence of benzo[a]pyrene--DNA adducts in different tissues of C57BL/10 and DBA/2 mice.
Brauze D; Mikstacka R; Baer-Dubowska W
Carcinogenesis; 1991 Sep; 12(9):1607-11. PubMed ID: 1909937
[TBL] [Abstract][Full Text] [Related]
31. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse.
Chang RL; Huang MT; Wood AW; Wong CQ; Newmark HL; Yagi H; Sayer JM; Jerina DM; Conney AH
Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336
[TBL] [Abstract][Full Text] [Related]
32. Formation and persistence of DNA adducts in different target tissues of rats after multiple administration of benzo[a]pyrene.
Qu SX; Stacey NH
Carcinogenesis; 1996 Jan; 17(1):53-9. PubMed ID: 8565137
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
34. Influence of the metabolic properties of human cells on the kinetic of formation of the major benzo[a]pyrene DNA adducts.
Marie C; Maître A; Douki T; Gateau M; Tarantini A; Guiraud P; Favier A; Ravanat JL
J Appl Toxicol; 2008 Jul; 28(5):579-90. PubMed ID: 17929235
[TBL] [Abstract][Full Text] [Related]
35. Carcinogenicity of benzo[a]pyrene and manufactured gas plant residues in infant mice.
Rodriguez LV; Dunsford HA; Steinberg M; Chaloupka KK; Zhu L; Safe S; Womack JE; Goldstein LS
Carcinogenesis; 1997 Jan; 18(1):127-35. PubMed ID: 9054599
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller.
Kim HS; Lee BM
Carcinogenesis; 1997 Apr; 18(4):771-6. PubMed ID: 9111213
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
[TBL] [Abstract][Full Text] [Related]
38. The effect of pentachlorophenol on DNA adduct formation in p53 wild-type and knockout mice exposed to benzo[a]pyrene.
Ress NB; Donnelly KC; George SE
Cancer Lett; 2002 Apr; 178(1):11-7. PubMed ID: 11849736
[TBL] [Abstract][Full Text] [Related]
39. In vivo localization and postmortem stability of benzo[a]pyrene-DNA adducts.
Poirier MC; Beland FA; Divi KV; Damon AL; Ali M; Vanlandingham MM; Churchwell MI; Von Tungeln LS; Dwyer JE; Divi RL; Beauchamp G; Martineau D
Environ Mol Mutagen; 2020 Feb; 61(2):216-223. PubMed ID: 31569280
[TBL] [Abstract][Full Text] [Related]
40. Benzo(a)pyrene diolepoxide-haemoglobin and albumin adducts at low levels of benzo(a)pyrene exposure.
Pastorelli R; Guanci M; Cerri A; Minoia C; Carrer P; Negri E; Fanelli R; Airoldi L
Biomarkers; 2000; 5(4):245-51. PubMed ID: 23885977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
